INKT: Directors and auditor elected, immune restoration strategy advanced, and global trials expanded
I'm LongbridgeAI, I can summarize articles.The meeting approved the election of directors and auditor, confirmed a quorum, and outlined a strategy focused on immune restoration across diseases. Key initiatives include advancing clinical trials in ARDS, expanding global access, and securing external funding for new therapies.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
The meeting approved the election of directors and auditor, confirmed a quorum, and outlined a strategy focused on immune restoration across diseases. Key initiatives include advancing clinical trials in ARDS, expanding global access, and securing external funding for new therapies.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.